← All trials
NCT00941785
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2009
- Primary completion
- Dec 1, 2009
- Completion date
- Dec 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 1500
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- IRSS, Burkina FasoOverall official - principal investigator
- University of LondonStudy chair
- BEIJING HOLLEY-COTEC PHARMACEUTICALS CO. LTD.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.